Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|October 1, 2019
Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed InfantsCarolyne Onyango-Makumbi, Arthur H Owora, Ramadhani S Mwiru, et al.Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2014
The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum womenVivek Naranbhai, Dhayendre Moodley, Tsungai Chipato, et al.AIDS and Behavior|February 20, 2016
HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline ResultsAudrey Pettifor, Catherine MacPhail, Amanda Selin, et al.Drug and Alcohol Review|June 20, 2026
Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and StaffRose A Schmidt, Amaya Perez-Brumer, Peter Davidson, et al.The Lancet. Global Health|November 6, 2016
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trialAudrey Pettifor, Catherine MacPhail, James P Hughes, et al.Human Vaccines & Immunotherapeutics|July 2, 2021
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participantsYunda Huang, Lily Zhang, Amanda Eaton, et al.JAMA Network Open|February 5, 2026
Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject DrugsNabila El-Bassel, Steven Shoptaw, Timothy Skalland, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 5, 2026
"Delivering high-quality care in this setting requires a lot of resources": HPTN 094 Implementation Lessons from Delivering Integrated HIV and MOUD Care Through Mobile Units In Local NeighborhoodsKiyomi Tsuyuki, Renee El-Krab, Steven Shoptaw, et al.Elife|February 4, 2015
Mucosal effects of tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.Pageof 6